Immuno-Oncology
Cancer Immunotherapy
Research-UseActive
Key Facts
About Resolve Biosciences
Resolve Biosciences is a private, commercial-stage company pioneering high-resolution spatial biology through its Molecular Cartography™ platform. The technology leverages true single-molecule RNA fluorescence in situ hybridization (smFISH) to map complex tissue ecosystems at subcellular resolution without the need for tissue clearing or signal amplification. The company targets the rapidly growing spatial biology and diagnostics market, with a primary focus on immuno-oncology, tumor pathology, and therapeutic development. Its end-to-end solution aims to translate spatial insights into clinically relevant biomarkers for improved patient stratification and treatment strategies.
View full company profileTherapeutic Areas
Other Cancer Immunotherapy Drugs
| Drug | Company | Phase |
|---|---|---|
| CYTER915 | FibroBiologics | Discovery |
| In vivo CAR-T Program | Deliver Biosciences | Pre-clinical |
| Novel Target Discovery | Noetik | Discovery |
| YB328 Microbiome Program | ARC Therapies | Research |
| Engineered Cancer Exosomes (HLA‑G Targeted) | Esco Aster | Preclinical |